This inventor holds 21 USPTO granted patents, plus 2 CIPO patents and 6 EPO patents, primarily in Dialysis Technology. Top assignee: Fresenius Medical Care Holdings, Inc.. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Walnut Creek, CA (US) (2015)
- Pleasant Hill, CA (US) (2015 - 2016)
- Concord, CA (US) (2017 - 2023)
- Martinez, CA (US) (2024)
Company Filing History:
Years Active: 2015-2026
Areas of Expertise:
Title: The Innovative Contributions of Matthew J. Doyle
Introduction
Matthew J. Doyle is a prominent inventor based in Walnut Creek, CA, known for his significant contributions to medical technology. With a total of 21 patents to his name, Doyle has made remarkable advancements in the field of extracorporeal blood treatment systems. His work focuses on improving the efficiency and effectiveness of medical fluid pumping systems.
Latest Patents
Doyle's latest patents include groundbreaking inventions such as "Determining a Modality of an Extracorporeal Blood Circuit." This patent relates to medical fluid pumping systems and outlines a blood treatment system that features a user interface and a processor. The system is designed to present instructions related to various modalities, including hemodialysis, hemofiltration, and hemodiafiltration. It intelligently eliminates modalities based on received information to optimize the blood treatment process.
Another notable patent is the "Extracorporeal Device and Method for Removal of Secondary Membrane." This invention addresses the challenge of removing a secondary membrane formed on a semipermeable membrane of a dialyzer during blood treatment. The device operates in two modes, effectively managing dialysate flow to ensure optimal performance and maintenance of the blood treatment system.
Career Highlights
Matthew J. Doyle is currently associated with Fresenius Medical Care Holdings, Inc., a leading company in the field of renal care and dialysis. His work at Fresenius has allowed him to apply his innovative ideas to real-world medical challenges, contributing to advancements in patient care and treatment options.
Collaborations
Doyle has collaborated with notable professionals in his field, including Lee Daniel Tanenbaum and Eric Hoffstetter. These collaborations have fostered a creative environment that encourages the development of cutting-edge medical technologies.
Conclusion
Matthew J. Doyle's contributions to medical technology through his patents and work at Fresenius Medical Care Holdings, Inc. highlight his dedication to improving patient outcomes in blood treatment. His innovative spirit continues to drive advancements in the medical field, making a lasting impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile